These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23116084)

  • 1. Systemic and biophase bioavailability and pharmacokinetics of nanoparticulate drug delivery systems.
    Leucuta SE
    Curr Drug Deliv; 2013 Apr; 10(2):208-40. PubMed ID: 23116084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery systems with modified release for systemic and biophase bioavailability.
    Leucuta SE
    Curr Clin Pharmacol; 2012 Nov; 7(4):282-317. PubMed ID: 22794159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.
    Das RP; Gandhi VV; Singh BG; Kunwar A
    Curr Pharm Des; 2019; 25(28):3034-3056. PubMed ID: 31470779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticulate drug delivery systems for cancer chemotherapy.
    Saha RN; Vasanthakumar S; Bende G; Snehalatha M
    Mol Membr Biol; 2010 Oct; 27(7):215-31. PubMed ID: 20939772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
    Uppal S; Italiya KS; Chitkara D; Mittal A
    Acta Biomater; 2018 Nov; 81():20-42. PubMed ID: 30268916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive and active drug targeting: drug delivery to tumors as an example.
    Torchilin VP
    Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
    Zhong Y; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of nanoparticulate drug delivery systems by intranasal administration.
    Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna
    Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress on triptolide functionalized nanoparticulate drug delivery systems for tumor treatment].
    Luo YY; Shi JF; Chen L; Li JX; Ma XY; Zhang JM; Geng FN
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4566-4572. PubMed ID: 31872649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
    Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
    Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction for Design of Nanoparticle Based Drug Delivery Systems.
    Edgar JYC; Wang H
    Curr Pharm Des; 2017; 23(14):2108-2112. PubMed ID: 27784242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.